VCA Stocks

Serenex: Drug development firm Serenex has closed on a $26 million round of financing, Serenex will use the funds to finance further development of two drug candidates targeting oncology as well as programs focused on antifungal, anti-neurodegenerative, antiviral and other non-oncology research.